Latest Margin Expansion News

Tasmea Limited forecasts a robust 34% increase in net profit after tax for FY26, driven by a record order book and strategic acquisitions, while reaffirming its FY25 earnings guidance.

Collins Foods reported a record $1.52 billion revenue for FY25 with flat EBITDA despite tough market conditions, while signaling optimism for low to mid-teens NPAT growth in FY26.

IVE Group has raised its FY25 underlying NPAT guidance to approximately $52 million, driven by margin expansion despite a slight revenue dip. The company also outlined ambitious growth plans targeting $1.25 billion in revenue by 2030, focusing on diversified, sustainable marketing solutions.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

BetMakers Technology Group launches a $13.5 million equity raise to fund the acquisition of Las Vegas Dissemination Company and strengthen its financial position amid improving operational metrics.

COSOL Limited anticipates solid revenue and earnings growth for FY25 despite some contract timing setbacks, with a promising outlook for FY26 driven by data analytics and managed services expansion.

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.

ikeGPS Group Limited (IKE) reported a robust FY25 with 19% revenue growth driven by subscription gains and improved margins, setting the stage for EBITDA break-even in FY26 H2 amid strong North American market demand.

ikeGPS Group Limited reported a robust 48% growth in annual subscription revenue exit run rate for FY25, alongside improved margins and a narrowed EBITDA loss. Despite a lucrative NZ$1 per share acquisition approach, the company declined the offer, confident in its growth trajectory.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

Straker Ltd has reported a record adjusted EBITDA of NZ$4.8 million for FY25, driven by strong growth in AI subscription services and operational efficiencies, even as overall revenue declined 10.3%. The company’s strategic pivot towards AI-powered offerings signals a promising shift in its business model.